专利内容由知识产权出版社提供
专利名称：METHOD AND PHARMACEUTICAL
COMPOSITION FOR INHIBITINGPI3K/AKT/MTOR SIGNAL PATH
发明人：DUAN, LEI,LEVENSON, VIKTOR,YING,
GUOGUANG
申请号：EP13841191申请日：20130929公开号：EP2905032A4公开日：20161116
摘要：The present invention relates to a pharmaceutical composition of PRCPantagonist, PREP antagonist, or PRCP-PREP dual antagonist. The present invention alsorelates to a pharmaceutical composition jointly using PRCP antagonist and mTORantagonist, or jointly using PREP antagonist and mTOR antagonist, or jointly using PRCP-PREP dual antagonist and mTOR antagonist. In addition, the present invention alsorelates to a method for utilizing the pharmaceutical compositions to treat and preventcancers and diseases related to insulin receptor substrate protein and PI3K/AKT/mTORsignal pathway.
申请人：TARGETED THERAPEUTICS, LLC
更多信息请下载全文后查看
